Discovery and development of sorafenib: a multikinase inhibitor for treating cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer

Published:2006-10-01 Issue:10 Volume:5 Page:835-844
ISSN:1474-1776
Container-title:Nature Reviews Drug Discovery
language:en
Short-container-title:Nat Rev Drug Discov

Author:

Wilhelm Scott,Carter Christopher,Lynch Mark,Lowinger Timothy,Dumas Jacques,Smith Roger A.,Schwartz Brian,Simantov Ronit,Kelley Susan

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology,General Medicine

Link

http://www.nature.com/articles/nrd2130.pdf

Reference92 articles.

1. Tabin, C. J. et al. Mechanism of activation of a human oncogene. Nature 300, 143–149 (1982).

2. Parada, L. F., Tabin, C. J., Shih, C. & Weinberg, R. A. Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 297, 474–478 (1982).

3. Weinberg, R. A. Tumor suppressor genes. Science 254, 1138–1146 (1991).

4. Gallo, R. C. & Wong-Staal, F. Retroviruses as etiologic agents of some animal and human leukemias and lymphomas and as tools for elucidating the molecular mechanism of leukemogenesis. Blood 60, 545–557 (1982).

5. Varmus, H. Retroviruses. Science 240, 1427–1435 (1988).

Cited by 1541 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel benzenesulfonamides as dual VEGFR2/FGFR1 inhibitors targeting breast cancer: Design, synthesis, anticancer activity and in silico studies;Bioorganic Chemistry;2024-11

2. Ag(I)-NHC/TBHP promoted aqueous synthesis of some new quinoline-aromatic amides; Anti-proliferative, Anti-VEGFR-2 and Molecular docking studies;Journal of Molecular Structure;2024-10

3. FDA-approved small molecule kinase inhibitors for cancer treatment (2001–2015): Medical indication, structural optimization, and binding mode Part I;Bioorganic & Medicinal Chemistry;2024-09

4. Non-kinase off-target inhibitory activities of clinically-relevant kinase inhibitors;European Journal of Medicinal Chemistry;2024-09

5. Integrated in silico and in vitro discovery of a new anticancer thiadiazole analog targeting VEGFR-2;Journal of Molecular Structure;2024-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3